Early definite stent thrombosis with everolimus‐eluting stents

Clinical Case Reports

Ryo Naito¹  Katsumi Miyauchi¹  Hirokazu Konishi¹  Shuta Tsuboi¹  Shinya Okazaki¹ 

[1] Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan

关键词: Coronary flow limitation;    CYP2C19 polymorphism;    everolimus‐eluting stent;    stent thrombosis;   

DOI  :  10.1002/ccr3.364

来源: Wiley

【 摘 要 】

Key Clinical Message

Stent thrombosis (ST) is a serious complication of percutaneous coronary intervention. Several factors are associated with ST, and combination of these factors increase the risk, even in everolimus-eluting stents, which have low risk of ST. We experienced a case of ST caused by limited coronary flow and resistance to antiplatelet agent.

【 授权许可】

CC BY-NC-ND   
© 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.